Loading...
The Impact of Differing Gleason Scores at Biopsy on the Odds of Upgrading and the Risk of Death from Prostate Cancer
BACKGROUND: The Gleason score (GS) is an established prostate cancer (PCa) prognostic factor. Whether the presence of differing GS’s at biopsy (e.g. 4 + 3 and 3 + 3), which we term ComboGS, improves the prognosis that would be predicted based on the highest GS (e.g.4 + 3) due to decreased upgrading...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4153802/ https://ncbi.nlm.nih.gov/pubmed/24721618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2014.02.008 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|